Cite
HARVARD Citation
Coghlan, G. et al. (n.d.). S109 Targeting the prostacyclin pathway in the treatment of connective tissue disease associated pulmonary arterial hypertension (pah): insights from the randomised controlled griphon trial with selexipag. Thorax. p. A65. [Online].